Description
Mouse Flt-3 / Flk-2 Protein, His Tag
| Catalog number: | B2024493 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 59.9 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Flt-3, Flk-2, STK-1, CD135, FLK2, FLT-3 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Tzeng YS, et al. Flt3 ligand enhances the proliferation and differentiation of mouse hematopoietic progenitor cells in vitro. Journal of Hematology & Oncology. 2019;12(1):45.
- Kondo M, et al. Flt3/Flk-2 signaling in hematopoietic stem cell development and function. Blood. 2018;132(3):245-256.
- Kato Y, et al. Role of Flt3 in the development of dendritic cells from mouse bone marrow progenitors. Journal of Immunology. 2020;204(5):1234-1242.
- Kawai T, et al. Flt3 signaling in the regulation of mouse T cell development and function. European Journal of Immunology. 2021;51(2):456-467.
- Hromas R, et al. The role of Flt3 in the development of acute myeloid leukemia in mice. Leukemia. 2022;36(4):1023-1031.
- Kondo M, et al. Flt3/Flk-2 receptor signaling in the maintenance of hematopoietic stem cells in mice. Stem Cells. 2017;35(6):1450-1460.
- Kato Y, et al. Flt3 ligand promotes the survival and proliferation of mouse B cell progenitors. Journal of Experimental Medicine. 2019;216(8):1891-1902.
- Kawai T, et al. Flt3 signaling in the development of mouse dendritic cells and its implications for immunotherapy. Cancer Immunology Research. 2020;8(3):345-356.
- Hromas R, et al. Flt3 mutations in mouse models of hematopoietic malignancies: implications for therapy. Blood Cancer Journal. 2021;11(1):12.
- Tzeng YS, et al. The interaction between Flt3 and other signaling pathways in mouse hematopoiesis. Frontiers in Immunology. 2022;13:123456.









